Literature DB >> 29955588

Improving CT screening for lung cancer with a highly predictive risk model.

Cristiano Rampinelli1, Marta Minotti2.   

Abstract

Entities:  

Year:  2018        PMID： 29955588      PMCID： PMC6015955          DOI： 10.21037/atm.2018.01.34

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  16 in total

1.  Results of the two incidence screenings in the National Lung Screening Trial.

Authors:  Denise R Aberle; Sarah DeMello; Christine D Berg; William C Black; Brenda Brewer; Timothy R Church; Kathy L Clingan; Fenghai Duan; Richard M Fagerstrom; Ilana F Gareen; Constantine A Gatsonis; David S Gierada; Amanda Jain; Gordon C Jones; Irene Mahon; Pamela M Marcus; Joshua M Rathmell; JoRean Sicks
Journal:  N Engl J Med       Date:  2013-09-05       Impact factor: 91.245

Review 2.  Lung cancer screening with low-dose CT in Europe: strength and weakness of diverse independent screening trials.

Authors:  M Silva; U Pastorino; N Sverzellati
Journal:  Clin Radiol       Date:  2017-02-04       Impact factor: 2.350

3.  Selection criteria for lung-cancer screening.

Authors:  Martin C Tammemägi; Hormuzd A Katki; William G Hocking; Timothy R Church; Neil Caporaso; Paul A Kvale; Anil K Chaturvedi; Gerard A Silvestri; Tom L Riley; John Commins; Christine D Berg
Journal:  N Engl J Med       Date:  2013-02-21       Impact factor: 91.245

4.  Targeting of low-dose CT screening according to the risk of lung-cancer death.

Authors:  Anil K Chaturvedi; Hormuzd A Katki; Stephanie A Kovalchik; Martin Tammemagi; Christine D Berg; Neil E Caporaso; Tom L Riley; Mary Korch; Gerard A Silvestri
Journal:  N Engl J Med       Date:  2013-07-18       Impact factor: 91.245

5.  Previous lung diseases and lung cancer risk: a pooled analysis from the International Lung Cancer Consortium.

Authors:  Darren R Brenner; Paolo Boffetta; Eric J Duell; Heike Bickeböller; Albert Rosenberger; Valerie McCormack; Joshua E Muscat; Ping Yang; H-Erich Wichmann; Irene Brueske-Hohlfeld; Ann G Schwartz; Michele L Cote; Anne Tjønneland; Søren Friis; Loic Le Marchand; Zuo-Feng Zhang; Hal Morgenstern; Neonila Szeszenia-Dabrowska; Jolanta Lissowska; David Zaridze; Peter Rudnai; Eleonora Fabianova; Lenka Foretova; Vladimir Janout; Vladimir Bencko; Miriam Schejbalova; Paul Brennan; Ioan N Mates; Philip Lazarus; John K Field; Olaide Raji; John R McLaughlin; Geoffrey Liu; John Wiencke; Monica Neri; Donatella Ugolini; Angeline S Andrew; Qing Lan; Wei Hu; Irene Orlow; Bernard J Park; Rayjean J Hung
Journal:  Am J Epidemiol       Date:  2012-09-17       Impact factor: 4.897

6.  Lung function predicts lung cancer risk in smokers: a tool for targeting screening programmes.

Authors:  E Calabrò; G Randi; C La Vecchia; N Sverzellati; A Marchianò; M Villani; M Zompatori; R Cassandro; S Harari; U Pastorino
Journal:  Eur Respir J       Date:  2009-08-13       Impact factor: 16.671

7.  Participant selection for lung cancer screening by risk modelling (the Pan-Canadian Early Detection of Lung Cancer [PanCan] study): a single-arm, prospective study.

Authors:  Martin C Tammemagi; Heidi Schmidt; Simon Martel; Annette McWilliams; John R Goffin; Michael R Johnston; Garth Nicholas; Alain Tremblay; Rick Bhatia; Geoffrey Liu; Kam Soghrati; Kazuhiro Yasufuku; David M Hwang; Francis Laberge; Michel Gingras; Sergio Pasian; Christian Couture; John R Mayo; Paola V Nasute Fauerbach; Sukhinder Atkar-Khattra; Stuart J Peacock; Sonya Cressman; Diana Ionescu; John C English; Richard J Finley; John Yee; Serge Puksa; Lori Stewart; Scott Tsai; Ehsan Haider; Colm Boylan; Jean-Claude Cutz; Daria Manos; Zhaolin Xu; Glenwood D Goss; Jean M Seely; Kayvan Amjadi; Harmanjatinder S Sekhon; Paul Burrowes; Paul MacEachern; Stefan Urbanski; Don D Sin; Wan C Tan; Natasha B Leighl; Frances A Shepherd; William K Evans; Ming-Sound Tsao; Stephen Lam
Journal:  Lancet Oncol       Date:  2017-10-18       Impact factor: 41.316

8.  Evaluation of the lung cancer risks at which to screen ever- and never-smokers: screening rules applied to the PLCO and NLST cohorts.

Authors:  Martin C Tammemägi; Timothy R Church; William G Hocking; Gerard A Silvestri; Paul A Kvale; Thomas L Riley; John Commins; Christine D Berg
Journal:  PLoS Med       Date:  2014-12-02       Impact factor: 11.069

9.  Lung cancer incidence and mortality in National Lung Screening Trial participants who underwent low-dose CT prevalence screening: a retrospective cohort analysis of a randomised, multicentre, diagnostic screening trial.

Authors:  Edward F Patz; Erin Greco; Constantine Gatsonis; Paul Pinsky; Barnett S Kramer; Denise R Aberle
Journal:  Lancet Oncol       Date:  2016-03-18       Impact factor: 41.316

10.  UK Lung Cancer RCT Pilot Screening Trial: baseline findings from the screening arm provide evidence for the potential implementation of lung cancer screening.

Authors:  J K Field; S W Duffy; D R Baldwin; D K Whynes; A Devaraj; K E Brain; T Eisen; J Gosney; B A Green; J A Holemans; T Kavanagh; K M Kerr; M Ledson; K J Lifford; F E McRonald; A Nair; R D Page; M K B Parmar; D M Rassl; R C Rintoul; N J Screaton; N J Wald; D Weller; P R Williamson; G Yadegarfar; D M Hansell
Journal:  Thorax       Date:  2015-12-08       Impact factor: 9.139
View more
  1 in total

1.  Long non-coding RNA TRPM2-AS sponges microRNA-138-5p to activate epidermal growth factor receptor and PI3K/AKT signaling in non-small cell lung cancer.

Authors:  Dong Cui; Yu Feng; Kefeng Shi; Huimin Zhang; Rulin Qian
Journal:  Ann Transl Med       Date:  2020-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.